Runbo Zhong
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 63
- Lung Cancer Research Studies 33
- Cancer Immunotherapy and Biomarkers 27
- Peptidase Inhibition and Analysis 7
-
- Lung Cancer Treatments and Mutations 41
- Lung Cancer Diagnosis and Treatment 18
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Baohui Han (62 shared papers)Hua Zhong (26 shared papers)Jiajun Teng (13 shared papers)Jianlin Xu (30 shared papers)Tianqing Chu (27 shared papers)Hua Zhong (13 shared papers)Hua Zhong (5 shared papers)Yanwei Zhang (11 shared papers)
- Journals
- Journal of Thoracic Oncology (7 papers)Frontiers in Immunology (5 papers)Translational Lung Cancer Research (5 papers)Lung Cancer (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Runbo Zhong
85 papers receiving 1.1k citations
Runbo Zhong's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 715
- Pulmonary and Respiratory Medicine 440
- Immunology 248
- Cancer Research 171
- Otorhinolaryngology 28
Countries citing papers authored by Runbo Zhong
This map shows the geographic impact of Runbo Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runbo Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runbo Zhong more than expected).
Fields of papers citing papers by Runbo Zhong
This network shows the impact of papers produced by Runbo Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runbo Zhong. The network helps show where Runbo Zhong may publish in the future.
Co-authors
The 25 scholars most cited alongside Runbo Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC Hit paper breakdown → | 2021 | 174 |
| 2 | 2011 | 72 | |
| 3 | 2018 | 67 | |
| 4 | 2019 | 48 | |
| 5 | 2021 | 42 | |
| 6 | 2018 | 41 | |
| 7 | 2013 | 38 | |
| 8 | 2019 | 38 | |
| 9 | 2015 | 36 | |
| 10 | 2020 | 35 | |
| 11 | 2020 | 33 | |
| 12 | 2022 | 25 | |
| 13 | 2021 | 23 | |
| 14 | 2024 | 23 | |
| 15 | 2023 | 21 | |
| 16 | 2021 | 21 | |
| 17 | 2019 | 18 | |
| 18 | 2022 | 18 | |
| 19 | 2016 | 15 | |
| 20 | 2010 | 15 |
About Runbo Zhong
Runbo Zhong is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Immunology, having authored 89 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (33 papers), Cancer Immunotherapy and Biomarkers (27 papers), Lung Cancer Diagnosis and Treatment (18 papers), Neuroendocrine Tumor Research Advances (11 papers), RNA modifications and cancer (9 papers), Peptidase Inhibition and Analysis (7 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (715 citations), Pulmonary and Respiratory Medicine (440 citations), Immunology (248 citations), Cancer Research (171 citations) and Otorhinolaryngology (28 citations). Runbo Zhong has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Baohui Han, Hua Zhong, Jiajun Teng, Jianlin Xu, Tianqing Chu, Hua Zhong, Hua Zhong, Yanwei Zhang, Jun Lü and Rong Qiao. Their work appears in journals such as Journal of Thoracic Oncology, Frontiers in Immunology, Translational Lung Cancer Research, Lung Cancer and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.